Skip to content
Search

Latest Stories

Over 70m doses of Covid-19 delivered so far

Over 70 million Covid-19 vaccines have been administered to the adults in the UK up until now, according to latest government figures.

A total of 29,165,140 million people have successfully received both the doses of the vaccine, totalling around 55.4 per cent of the population.


The exact number of doses administered so far are 70,253,625 million in total, while 41,088,485 million people across the UK received their first dose of vaccine (78 per cent).

Health secretary Matt Hancock said: “Our Covid-19 vaccination programme continues at an unparalleled pace and we are almost at the final lap of the race to offer a dose to all adults by the end of July.”

He added: “70 million total doses is a phenomenal achievement. It’s truly heartening to think that this provides 70 million shots of protection and hope for a country that has battled to keep the infection under control over the past 18 months.”

Urging all those who are eligible to get their jab at the earliest possible opportunity, Hancock said the appointments booked over the past few days have shown the nation’s “enthusiasm” towards getting vaccinated.

According to a recent study by Public Health England (PHE), two doses of the Covid-19 vaccines are highly effective against the Delta (B.1.617.2) variant.

Vaccine efficacy against symptomatic disease from the Delta (B.1.617.2) variant is similar after two doses compared to the Alpha (B.1.1.7) variant. We expect to see even higher levels of effectiveness against hospitalisation and death, Hancock said.

More For You

First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less